A recent study describes the yield and clinical utility of epilepsy gene panel testing in a cohort of adults with epilepsy and intellectual disability. These findings are similar to those in children with developmental epileptic encephalopathies and support the utility of testing in this subgroup of adults with epilepsy.
References
Hesdorffer, D. C. et al. Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology 76, 23–27 (2011).
Chen, Z., Brodie, M. J., Liew, D. & Kwan, P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 75, 279–286 (2018).
EpiPM Consortium. A roadmap for precision medicine in the epilepsies. Lancet Neurol. 14, 1219–1228 (2015).
Ellis, C. A., Petrovski, S. & Berkovic, S. F. Epilepsy genetics: clinical impacts and biological insights. Lancet Neurol. 19, 93–100 (2020).
Epi4K Consortium & Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature 501, 217–221 (2013).
Poduri, A., Sheidley, B. R., Shostak, S. & Ottman, R. Genetic testing in the epilepsies-developments and dilemmas. Nat. Rev. Neurol. 10, 293–299 (2014).
Johannesen, K. M. et al. Utility of genetic testing for therapeutic decision-making in adults with epilepsy. Epilepsia https://doi.org/10.1111/epi.16533 (2020).
Borlot, F. et al. Clinical utility of multigene panel testing in adults with epilepsy and intellectual disability. Epilepsia 60, 1661–1669 (2019).
Symonds, J. D. et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain 142, 2303–2318 (2019).
Peljto, A. L. et al. Familial risk of epilepsy: a population-based study. Brain 137, 795–805 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ottman, R., Poduri, A. Gene tests in adults with epilepsy and intellectual disability. Nat Rev Neurol 16, 527–528 (2020). https://doi.org/10.1038/s41582-020-0388-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-020-0388-5
- Springer Nature Limited